Gardasil is currently the only cervical cancer vaccine on the market. It is only recommended for girls and women from 9 to 26 years of age. However, the FDA may expand the use to include women up to 45. The decision is expected by this summer.
Gardasil is currently the only cervical cancer vaccine on the market. It is only recommended for girls and women from 9 to 26 years of age. However, the FDA may expand the use to include women up to 45. The decision is expected by this summer.